Antibody–Drug Conjugates for Cancer Therapy

Author： Parslow Adam C.   Parakh Sagun   Lee Fook-Thean   Gan Hui K.   Scott Andrew M.  

Publisher： MDPI

E-ISSN： 2227-9059|4|3|14-14

ISSN： 2227-9059

Source： Biomedicines, Vol.4, Iss.3, 2016-07, pp. : 14-14

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

By Chen Hao   Lin Zongtao   Arnst Kinsie E.   Miller Duane D.   Li Wei  

Molecules, Vol. 22, Iss. 8, 2017-08 ,pp. : 1281-1281

MDPI

Access to resources Recommend Favorite

Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)

By Yao Houzong   Jiang Feng   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 194-194

MDPI

Access to resources Recommend Favorite

Linkers Having a Crucial Role in Antibody–Drug Conjugates

By Lu Jun   Jiang Feng   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 561-561

MDPI

Access to resources Recommend Favorite

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice

By Janthur Wolf-Dieter   Cantoni Nathan   Mamot Christoph  

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-11 ,pp. : 16020-16045

MDPI

Access to resources Recommend Favorite

Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy

By Mehrling Thomas   Soltis Daniel  

Antibodies, Vol. 7, Iss. 1, 2018-02 ,pp. : 11-11

MDPI

Access to resources Recommend Favorite